Deerfield Management Company — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Clinical-stage biotech developing next-generation polyene antifungals for life-threatening invasive fungal infections.
BiotechNew York, US
Kieren Marr(Executive Officer, Director)
BoardJim Flynn(Director)Martin Heidecker(Director)in
Board seatJonathan Leff· per SEC Form D · $83.8M raise · filed Jun 2024
Co-investorsAMR Action FundIllinois Ventures
MMI develops the Symani Surgical System, a robotic platform with NanoWrist instruments designed for microsurgery and supermicrosurgery, enabling surgeons to perform delicate procedures such as dissection and anastomosis.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)Andrew Cleeland(Director)Justin Lynch(Director)Theresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Board seatAndrew ElBardissi· per SEC Form D · $110M raise · filed Mar 2024
Co-investorsAndera PartnersCorewell Health VenturesFountain Healthcare Partners
Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US
Siva Namasivayam(Executive Officer, Director)Robert Shepardson(Executive Officer)Kristen Carucci(Executive Officer)Duncan Reese(Executive Officer)
BoardDavid Barrett(Director)Amir Debourou(Director)
Co-investorsCota CapitalFlare Capital PartnersLongitude CapitalDefine VenturesFlare Capital StrategiesTemasek
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.